Logo image of MCS

MARCUS CORPORATION (MCS) Stock Fundamental Analysis

USA - NYSE:MCS - US5663301068 - Common Stock

13.92 USD
+0.18 (+1.31%)
Last: 10/22/2025, 11:40:20 AM
Fundamental Rating

4

Overall MCS gets a fundamental rating of 4 out of 10. We evaluated MCS against 80 industry peers in the Entertainment industry. MCS has a medium profitability rating, but doesn't score so well on its financial health evaluation. MCS is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

MCS had positive earnings in the past year.
In the past year MCS had a positive cash flow from operations.
In the past 5 years MCS reported 4 times negative net income.
MCS had a positive operating cash flow in 4 of the past 5 years.
MCS Yearly Net Income VS EBIT VS OCF VS FCFMCS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M -150M

1.2 Ratios

MCS has a better Return On Assets (1.46%) than 63.75% of its industry peers.
The Return On Equity of MCS (3.30%) is better than 66.25% of its industry peers.
The Return On Invested Capital of MCS (2.26%) is better than 63.75% of its industry peers.
MCS had an Average Return On Invested Capital over the past 3 years of 1.74%. This is significantly below the industry average of 9.23%.
The 3 year average ROIC (1.74%) for MCS is below the current ROIC(2.26%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.46%
ROE 3.3%
ROIC 2.26%
ROA(3y)-0.16%
ROA(5y)-2.82%
ROE(3y)-0.39%
ROE(5y)-7.15%
ROIC(3y)1.74%
ROIC(5y)N/A
MCS Yearly ROA, ROE, ROICMCS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

MCS has a Profit Margin of 1.91%. This is in the better half of the industry: MCS outperforms 61.25% of its industry peers.
MCS has a Operating Margin of 3.66%. This is in the better half of the industry: MCS outperforms 65.00% of its industry peers.
In the last couple of years the Operating Margin of MCS has declined.
MCS has a Gross Margin of 38.85%. This is comparable to the rest of the industry: MCS outperforms 47.50% of its industry peers.
In the last couple of years the Gross Margin of MCS has remained more or less at the same level.
Industry RankSector Rank
OM 3.66%
PM (TTM) 1.91%
GM 38.85%
OM growth 3YN/A
OM growth 5Y-18.51%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.86%
GM growth 5Y-0.54%
MCS Yearly Profit, Operating, Gross MarginsMCS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MCS is destroying value.
The number of shares outstanding for MCS has been reduced compared to 1 year ago.
Compared to 5 years ago, MCS has more shares outstanding
Compared to 1 year ago, MCS has an improved debt to assets ratio.
MCS Yearly Shares OutstandingMCS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
MCS Yearly Total Debt VS Total AssetsMCS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of 1.54, we must say that MCS is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.54, MCS perfoms like the industry average, outperforming 55.00% of the companies in the same industry.
MCS has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.40, MCS perfoms like the industry average, outperforming 45.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Altman-Z 1.54
ROIC/WACC0.32
WACC7.08%
MCS Yearly LT Debt VS Equity VS FCFMCS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 0.39 indicates that MCS may have some problems paying its short term obligations.
MCS has a Current ratio of 0.39. This is amonst the worse of the industry: MCS underperforms 85.00% of its industry peers.
A Quick Ratio of 0.39 indicates that MCS may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.39, MCS is doing worse than 83.75% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.39
Quick Ratio 0.39
MCS Yearly Current Assets VS Current LiabilitesMCS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

4

3. Growth

3.1 Past

MCS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 159.21%, which is quite impressive.
The Revenue has grown by 13.27% in the past year. This is quite good.
The Revenue has been decreasing by -2.17% on average over the past years.
EPS 1Y (TTM)159.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%135.94%
Revenue 1Y (TTM)13.27%
Revenue growth 3Y17.09%
Revenue growth 5Y-2.17%
Sales Q2Q%17.05%

3.2 Future

The Earnings Per Share is expected to grow by 61.52% on average over the next years. This is a very strong growth
Based on estimates for the next years, MCS will show a small growth in Revenue. The Revenue will grow by 4.45% on average per year.
EPS Next Y245.02%
EPS Next 2Y111.81%
EPS Next 3Y61.52%
EPS Next 5YN/A
Revenue Next Year6.39%
Revenue Next 2Y5.3%
Revenue Next 3Y4.45%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MCS Yearly Revenue VS EstimatesMCS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
MCS Yearly EPS VS EstimatesMCS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -2 -4

5

4. Valuation

4.1 Price/Earnings Ratio

MCS is valuated quite expensively with a Price/Earnings ratio of 30.93.
77.50% of the companies in the same industry are more expensive than MCS, based on the Price/Earnings ratio.
MCS's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.77.
MCS is valuated rather expensively with a Price/Forward Earnings ratio of 21.53.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MCS indicates a rather cheap valuation: MCS is cheaper than 81.25% of the companies listed in the same industry.
MCS is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.23, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 30.93
Fwd PE 21.53
MCS Price Earnings VS Forward Price EarningsMCS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

MCS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. MCS is cheaper than 86.25% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.13
MCS Per share dataMCS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

MCS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MCS's earnings are expected to grow with 61.52% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.13
PEG (5Y)N/A
EPS Next 2Y111.81%
EPS Next 3Y61.52%

4

5. Dividend

5.1 Amount

MCS has a Yearly Dividend Yield of 2.44%.
In the last 3 months the price of MCS has falen by -22.06%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
Compared to an average industry Dividend Yield of 38.93, MCS pays a better dividend. On top of this MCS pays more dividend than 92.50% of the companies listed in the same industry.
MCS's Dividend Yield is comparable with the S&P500 average which is at 2.36.
Industry RankSector Rank
Dividend Yield 2.44%

5.2 History

The dividend of MCS decreases each year by -13.79%.
MCS has paid a dividend for at least 10 years, which is a reliable track record.
MCS has decreased its dividend in the last 3 years.
Dividend Growth(5Y)-13.79%
Div Incr Years2
Div Non Decr Years2
MCS Yearly Dividends per shareMCS Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

58.72% of the earnings are spent on dividend by MCS. This is a bit on the high side, but may be sustainable.
DP58.72%
EPS Next 2Y111.81%
EPS Next 3Y61.52%
MCS Yearly Income VS Free CF VS DividendMCS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M
MCS Dividend Payout.MCS Dividend Payout, showing the Payout Ratio.MCS Dividend Payout.PayoutRetained Earnings

MARCUS CORPORATION

NYSE:MCS (10/22/2025, 11:40:20 AM)

13.92

+0.18 (+1.31%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)08-01 2025-08-01/bmo
Earnings (Next)10-29 2025-10-29/bmo
Inst Owners78.83%
Inst Owner Change-0.02%
Ins Owners4.98%
Ins Owner Change0.18%
Market Cap435.84M
Revenue(TTM)775.79M
Net Income(TTM)14.80M
Analysts84.44
Price Target25.5 (83.19%)
Short Float %3.73%
Short Ratio3.55
Dividend
Industry RankSector Rank
Dividend Yield 2.44%
Yearly Dividend0.28
Dividend Growth(5Y)-13.79%
DP58.72%
Div Incr Years2
Div Non Decr Years2
Ex-Date08-25 2025-08-25 (0.08)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.53%
Min EPS beat(2)-10.24%
Max EPS beat(2)15.3%
EPS beat(4)2
Avg EPS beat(4)-2.7%
Min EPS beat(4)-73%
Max EPS beat(4)57.12%
EPS beat(8)3
Avg EPS beat(8)-322.91%
EPS beat(12)5
Avg EPS beat(12)-221.55%
EPS beat(16)8
Avg EPS beat(16)-136.28%
Revenue beat(2)2
Avg Revenue beat(2)3.53%
Min Revenue beat(2)1.76%
Max Revenue beat(2)5.29%
Revenue beat(4)4
Avg Revenue beat(4)4.38%
Min Revenue beat(4)1.76%
Max Revenue beat(4)8.6%
Revenue beat(8)7
Avg Revenue beat(8)3.4%
Revenue beat(12)11
Avg Revenue beat(12)3.65%
Revenue beat(16)15
Avg Revenue beat(16)6.74%
PT rev (1m)0%
PT rev (3m)-0.99%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-21.47%
EPS NY rev (1m)0%
EPS NY rev (3m)-16.42%
Revenue NQ rev (1m)-1.69%
Revenue NQ rev (3m)-5.34%
Revenue NY rev (1m)-0.1%
Revenue NY rev (3m)-0.16%
Valuation
Industry RankSector Rank
PE 30.93
Fwd PE 21.53
P/S 0.56
P/FCF N/A
P/OCF 5.49
P/B 0.97
P/tB 1.17
EV/EBITDA 6.13
EPS(TTM)0.45
EY3.23%
EPS(NY)0.65
Fwd EY4.64%
FCF(TTM)-0.14
FCFYN/A
OCF(TTM)2.54
OCFY18.21%
SpS24.78
BVpS14.32
TBVpS11.93
PEG (NY)0.13
PEG (5Y)N/A
Graham Number12.04
Profitability
Industry RankSector Rank
ROA 1.46%
ROE 3.3%
ROCE 3.3%
ROIC 2.26%
ROICexc 2.3%
ROICexgc 2.52%
OM 3.66%
PM (TTM) 1.91%
GM 38.85%
FCFM N/A
ROA(3y)-0.16%
ROA(5y)-2.82%
ROE(3y)-0.39%
ROE(5y)-7.15%
ROIC(3y)1.74%
ROIC(5y)N/A
ROICexc(3y)1.83%
ROICexc(5y)N/A
ROICexgc(3y)2.03%
ROICexgc(5y)N/A
ROCE(3y)2.54%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-14.17%
ROICexc growth 3YN/A
ROICexc growth 5Y-14.65%
OM growth 3YN/A
OM growth 5Y-18.51%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.86%
GM growth 5Y-0.54%
F-Score7
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Debt/EBITDA 1.81
Cap/Depr 118.61%
Cap/Sales 10.81%
Interest Coverage 3.38
Cash Conversion 80.12%
Profit Quality N/A
Current Ratio 0.39
Quick Ratio 0.39
Altman-Z 1.54
F-Score7
WACC7.08%
ROIC/WACC0.32
Cap/Depr(3y)76.34%
Cap/Depr(5y)56.25%
Cap/Sales(3y)7.17%
Cap/Sales(5y)6.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)159.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%135.94%
EPS Next Y245.02%
EPS Next 2Y111.81%
EPS Next 3Y61.52%
EPS Next 5YN/A
Revenue 1Y (TTM)13.27%
Revenue growth 3Y17.09%
Revenue growth 5Y-2.17%
Sales Q2Q%17.05%
Revenue Next Year6.39%
Revenue Next 2Y5.3%
Revenue Next 3Y4.45%
Revenue Next 5YN/A
EBIT growth 1Y209.42%
EBIT growth 3YN/A
EBIT growth 5Y-20.28%
EBIT Next Year312.54%
EBIT Next 3Y65.19%
EBIT Next 5YN/A
FCF growth 1Y-109.14%
FCF growth 3Y-5.39%
FCF growth 5Y-20.4%
OCF growth 1Y-6.95%
OCF growth 3Y30.94%
OCF growth 5Y-5.98%